Skyline Medical Company Profile (NASDAQ:SKLN)

About Skyline Medical (NASDAQ:SKLN)

Skyline Medical logoSkyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed. The Company also manufactures and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap, and a single use bottle of cleaning solution. Both items are used on a single procedure basis. Its STREAMWAY Automated Surgical Fluid Waste Management System (FMS) is a wall mounted automated system that disposes of an unlimited amount of suctioned fluid from the patient using standard surgical tubing. The FMS suctions surgical waste fluid from the patient using standard surgical tubing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SKLN
  • CUSIP: N/A
  • Web:
  • Market Cap: $8.72 million
  • Outstanding Shares: 6,232,000
Average Prices:
  • 50 Day Moving Avg: $1.40
  • 200 Day Moving Avg: $1.51
  • 52 Week Range: $1.36 - $6.05
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $556,156.00
  • Price / Sales: 15.69
  • Book Value: $0.52 per share
  • Price / Book: 2.69
  • EBIDTA: ($5,600,000.00)
  • Net Margins: -1,018.85%
  • Return on Equity: -280.36%
  • Return on Assets: -154.42%
  • Current Ratio: 3.46%
  • Quick Ratio: 3.26%
  • Average Volume: 110,917 shs.
  • Beta: 0.23
  • Short Ratio: 2.43

Frequently Asked Questions for Skyline Medical (NASDAQ:SKLN)

What is Skyline Medical's stock symbol?

Skyline Medical trades on the NASDAQ under the ticker symbol "SKLN."

How were Skyline Medical's earnings last quarter?

Skyline Medical Inc. (NASDAQ:SKLN) posted its quarterly earnings results on Monday, August, 14th. The company reported ($0.41) earnings per share (EPS) for the quarter. The firm had revenue of $0.11 million for the quarter. Skyline Medical had a negative net margin of 1,018.85% and a negative return on equity of 280.36%. View Skyline Medical's Earnings History.

When will Skyline Medical make its next earnings announcement?

Skyline Medical is scheduled to release their next quarterly earnings announcement on Tuesday, November, 21st 2017. View Earnings Estimates for Skyline Medical.

Who are some of Skyline Medical's key competitors?

Who are Skyline Medical's key executives?

Skyline Medical's management team includes the folowing people:

  • Carl Schwartz, President, Chief Executive Officer, Director
  • Robert L Myers, Chief Financial Officer
  • David O Johnson, Chief Operating Officer
  • J. Melville Engle, Director
  • Richard L. Gabriel, Director
  • Ricardo Koenigsberger, Director
  • Timothy A. Krochuk, Director
  • Frank G. Mancuso Jr., Director

Who owns Skyline Medical stock?

Skyline Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.61%). View Institutional Ownership Trends for Skyline Medical.

Who bought Skyline Medical stock? Who is buying Skyline Medical stock?

Skyline Medical's stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Skyline Medical.

How do I buy Skyline Medical stock?

Shares of Skyline Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Skyline Medical's stock price today?

One share of Skyline Medical stock can currently be purchased for approximately $1.40.

MarketBeat Community Rating for Skyline Medical (NASDAQ SKLN)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  40
MarketBeat's community ratings are surveys of what our community members think about Skyline Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Skyline Medical (NASDAQ:SKLN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Skyline Medical (NASDAQ:SKLN)
No equities research coverage for this company has been tracked by


Earnings History for Skyline Medical (NASDAQ:SKLN)
Earnings by Quarter for Skyline Medical (NASDAQ:SKLN)
Earnings History by Quarter for Skyline Medical (NASDAQ SKLN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2017Q2 2017($0.41)$0.11 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.21)$0.18 millionViewN/AView Earnings Details
11/15/2016Q3 2016($0.32)$0.14 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Skyline Medical (NASDAQ:SKLN)

No earnings estimates for this company have been tracked by


Dividend History for Skyline Medical (NASDAQ:SKLN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Skyline Medical (NASDAQ:SKLN)
Insider Ownership Percentage: 10.79%
Institutional Ownership Percentage: 3.29%
Insider Trades by Quarter for Skyline Medical (NASDAQ:SKLN)
Insider Trades by Quarter for Skyline Medical (NASDAQ:SKLN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2014Samuel HerschkowitzMajor ShareholderBuy210,680$0.11$23,174.80View SEC Filing  
9/15/2014Robert L MyersCFOBuy5,000$0.13$650.00View SEC Filing  
8/27/2014David O JohnsonCOOBuy14,300$0.14$2,002.00View SEC Filing  
8/22/2014Robert L MyersCFOBuy5,000$0.15$750.00View SEC Filing  
8/19/2014Samuel HerschkowitzMajor ShareholderBuy2,000$0.12$240.00View SEC Filing  
7/23/2014Samuel HerschkowitzMajor ShareholderBuy25,000$0.13$3,250.00View SEC Filing  
7/14/2014Samuel HerschkowitzMajor ShareholderBuy6,200$0.13$806.00View SEC Filing  
5/22/2014Samuel HerschkowitzMajor ShareholderBuy66,000$0.13$8,580.00View SEC Filing  
4/30/2014Samuel HerschkowitzMajor ShareholderBuy61,500$0.13$7,995.00View SEC Filing  
3/27/2014Samuel HerschkowitzMajor ShareholderBuy21,812$0.19$4,144.28View SEC Filing  
3/18/2014Samuel HerschkowitzMajor ShareholderBuy23,000$0.21$4,830.00View SEC Filing  
12/13/2013Arnon I DreyfussDirectorBuy5,021$0.24$1,205.04View SEC Filing  
11/26/2013Samuel HerschkowitzMajor ShareholderBuy10,000$0.29$2,900.00View SEC Filing  
11/25/2013Arnon I DreyfussDirectorBuy25,000$0.27$6,750.00View SEC Filing  
11/20/2013Samuel HerschkowitzMajor ShareholderBuy25,500$0.28$7,140.00View SEC Filing  
8/16/2013Samuel HerschkowitzMajor ShareholderBuy23,000$0.21$4,830.00View SEC Filing  
8/6/2013Arnon I DreyfussDirectorBuy20,000$0.22$4,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Skyline Medical (NASDAQ:SKLN)
Latest Headlines for Skyline Medical (NASDAQ:SKLN)
DateHeadline logoSkyline Medical Enters Innovative Technology Partnership with Intalere for STREAMWAY® System - September 6 at 8:20 AM logoSkyline Medical, Inc. :SKLN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 - August 24 at 12:45 PM logoDr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies - August 17 at 7:38 AM logoLink Revised - Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies - August 17 at 7:38 AM logoSkyline Medical Inc. (SKLN) Posts Quarterly Earnings Results - August 15 at 10:48 AM logoSkyline Medical Reports 2017 Second Quarter Financial Results - August 15 at 7:01 AM logoSan Antonio and Minnesota biotech companies closer to joining forces - August 10 at 7:56 AM logoSkyline Medical Signs Definitive Merger Agreement With CytoBioscience - August 10 at 7:56 AM logoSkyline Medical's FDA-Approved "STREAMWAY(R)" is Technology to Watch - August 9 at 7:30 AM logoWall Street's M&A Chatter From August 1: EW Scripps-Katz Broadcast, Innophos-Novel, Skyline Medical-CytoBioscience - August 2 at 4:29 PM logoSA biotech CytoBioscience nearing merger with Midwest company - August 1 at 8:58 PM logoSkyline Medical Signs Binding Letter of Intent for Merger Transaction with CytoBioscience - August 1 at 3:54 PM logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Skyline Medical Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors - July 13 at 9:31 AM logoSkyline Medical Issues Letter to Stockholders - June 30 at 6:42 AM logoForm 8-K Skyline Medical Inc. For: Jun 15 - June 22 at 1:35 PM logoSkyline Medical (SKLN) Receives CE Mark for STREAMWAY System - June 15 at 4:50 PM logoSkyline Medical Announces CE Mark for the STREAMWAY® System - June 15 at 4:50 PM



Skyline Medical (SKLN) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff